TICKERNERD
Menu
PREPREConsumer Defensive · Packaged Foods

PRE Stock Forecast: Prenetics Global Ltd. Price Predictions for 2026-2027

Last close, 6 Aug 2026
$18

The 3 Wall Street analysts covering Prenetics Global Ltd. hold a median 12-month price target of $35 — +96.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 39 of 100 as at 6 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$313.8M
Ticker Nerd rank
39 / 100
Median analyst target
$35
Analysts covering
3
Ticker Nerd rank

PRE stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Prenetics Global Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 6 Aug 2026
39 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
79
Momentum
78
Size
62
Issuance
55
Accruals
52
Revisions
40
Volatility
29
Quality
20
Value
12

Growth (79): Sales and profits are climbing, and climbing faster than before.

Value (12): The shares cost a lot relative to the profits and assets behind them.

The rank is the raw material. Whether the rules would actually own Prenetics Global Ltd. — and when they’d sell — is the membership.

Wall Street

PRE stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PRE, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $30Median $35High $40

The green dot is the last close — the median target sits +96.0% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 8 moved their price target up and 2 moved it down.

DateFirmActionRatingTarget
15 July 2026BenchmarkMaintainsBuy$30 → $40
16 June 2026BenchmarkInitiatesBuy—
16 Mar 2026Lake StreetInitiatesBuy—
29 Oct 2025Cantor FitzgeraldMaintainsOverweight—
16 Jan 2025Cantor FitzgeraldReiteratesOverweight—
4 Dec 2024Cantor FitzgeraldReiteratesOverweight—
4 Apr 2024Cantor FitzgeraldMaintainsOverweight—
26 Sept 2023Cantor FitzgeraldReiteratesOverweight$4.00
19 Sept 2023Cantor FitzgeraldMaintainsOverweight$6.00 → $4.00
22 Aug 2023Cantor FitzgeraldReiteratesOverweight—
18 Jan 2023Cantor FitzgeraldInitiatesOverweight$7.00
28 July 2015BarclaysMaintainsOverweight$137 → $140
9 July 2015Deutsche BankMaintainsHold$6.50 → $6.10
18 June 2015Keefe, Bruyette & WoodsMaintainsMarket Perform$138 → $140
13 May 2015BMO CapitalMaintainsMarket Perform$130 → $138
6 May 2015Deutsche BankMaintainsHold$6.10 → $6.50
22 Apr 2015UBSDowngradeNeutral—
20 Apr 2015Deutsche BankMaintainsHold$125 → $130
17 Apr 2015BMO CapitalDowngradeMarket Perform$122 → $130
26 Mar 2015BMO CapitalUpgradeOutperform$114 → $122

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

PRE analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

Prenetics Global Ltd. (PRE) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
1.1×

Cheaper than 70% of US stocks

Price / sales
2.6×

Cheaper than 46% of US stocks

Price / book
2.6×

Cheaper than 39% of US stocks

EV / EBITDA
−4.9×

Cheaper than 79% of US stocks

Growth & margins
Revenue growth (YoY)
107.7%

Higher than 94% of US stocks

Earnings growth (YoY)
107.7%

Higher than 87% of US stocks

Gross margin
64.8%

Higher than 79% of US stocks

Operating margin
−24.7%

Higher than 21% of US stocks

Net margin
−42.0%

Higher than 11% of US stocks

Returns & dividend
Return on equity
−40.8%

Higher than 23% of US stocks

Return on assets
−13.5%

Higher than 24% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

PRE vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPackaged Foods
CompanyMarket capTKN rank
PREPrenetics Global Ltd.$313.8M
39
BGSB&G Foods, Inc.$273.5M
69
USNAUSANA Health Sciences, Inc.$272.2M
65
BYNDBeyond Meat, Inc.$271.8M
29
NATRNature's Sunshine Products, Inc.$355.9M
93
BRCCBRC, Inc.$237.9M
84
LWAYLifeway Foods, Inc.$470.5M
50
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PRE appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest PRE news & analysis

Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation

GlobeNewsWire · 7 Aug 2026neutral

Prenetics announced it will report its Q2 2026 financial results on August 18, 2026, host a live-stream earnings event on Stocktwits, and disclosed upcoming conference participation.

Why it matters — Investors and followers of PRE will have access to the company's quarterly performance figures and an interactive earnings discussion via Stocktwits, as well as visibility into the company's upcoming investor-relations activities.

FAQ

Frequently asked questions about PRE stock

What is the PRE stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Prenetics Global Ltd. have a median 12-month price target of $35, with estimates ranging from $30 to $40. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is PRE stock a buy right now?

Of the 3 analysts covering Prenetics Global Ltd., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Prenetics Global Ltd. 39 out of 100 across roughly 4,600 US stocks as at 6 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PRE?

As at 6 Aug 2026, Prenetics Global Ltd. ranks 39 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (79 of 100).

Will PRE stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +96.0% from the last close, and Ticker Nerd's factor model ranks Prenetics Global Ltd. 39 out of 100 as at 6 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the PRE stock forecast for 2030?

No analyst covering Prenetics Global Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PRE are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $30 to $40 over the next 12 months.

What does Prenetics Global Ltd. do?

Prenetics Global Limited is a health sciences company headquartered in Hong Kong that specializes in early detection, prevention, and treatment of diseases, particularly cancer, through genomic testing and wellness solutions. The company operates three primary business segments: Prevention, through CircleDNA, a direct-to-consumer genetic testing brand utilizing next-generation sequencing technology to provide comprehensive health and wellness insights; Diagnostics, through ACT Genomics, which offers precision oncology testing services and became the first Asia-based company to receive FDA clearance for comprehensive genomic profiling of solid tumors; and Consumer Health, featuring IM8 Health, a supplement and wellness brand, and Europa, a sports nutrition distribution company.

What is the latest news on PRE?

The most recent item we track (GlobeNewsWire, 7 Aug 2026): "Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation". Prenetics announced it will report its Q2 2026 financial results on August 18, 2026, host a live-stream earnings event on Stocktwits, and disclosed upcoming conference participation.

Company

About Prenetics Global Ltd.

Prenetics Global Limited is a health sciences company headquartered in Hong Kong that specializes in early detection, prevention, and treatment of diseases, particularly cancer, through genomic testing and wellness solutions. The company operates three primary business segments: Prevention, through CircleDNA, a direct-to-consumer genetic testing brand utilizing next-generation sequencing technology to provide comprehensive health and wellness insights; Diagnostics, through ACT Genomics, which offers precision oncology testing services and became the first Asia-based company to receive FDA clearance for comprehensive genomic profiling of solid tumors; and Consumer Health, featuring IM8 Health, a supplement and wellness brand, and Europa, a sports nutrition distribution company. Prenetics' consumer DNA tests use whole-exome sequencing, providing significantly more genetic data than traditional array-based methods. The company distributes its products globally through retail partnerships, online platforms, and healthcare providers across Hong Kong, Taiwan, the United States, and other international markets, serving individual consumers, healthcare professionals, and institutions seeking science-backed solutions for health optimization and disease management.

CEO Mr. Sheng Wu Yeung · 98 employees · Hong Kong · https://www.prenetics.com